David Jin bought $3,750 of FBIO
Chief Financial Officer at Fortress Biotech, Inc.. 500 shares at an average of $7.50, traded Jul 10, 2024, filed Jul 12, 2024.
Score components
- +22RoleCFO
- 0Trade size$4k at market
- +8Relative to holdingsFirst purchase: no shares before this trade
- +8Price context82% below the 52-week high
- +8Cluster2 insiders buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (1 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -5.2%, 3m -15.5%, 6m +5.2%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001104659-24-079409, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jul 10, 2024 | POpen-market purchase SERIES A CUMULATIVE PERPETUAL PREFERRED STOCK | +500 | $7.50 | $3,750 | 500 | Jul 12, 2024 |
Related signals
Other insiders at Fortress Biotech, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 79Notable | FBIObuy Fortress Biotech, Inc. | Lindsay A Rosenwald Md PRESIDENT, CEO & CHAIRMAN | $1.4M 763,359 shares | +26% | |
| 52Moderate | Fortress Biotech, Inc. | Lindsay A Rosenwald Md President, CEO & Chairman | $37k 5,000 shares | +4% | |
| 52Moderate | Fortress Biotech, Inc. | Lindsay A Rosenwald Md President, CEO & Chairman | $37k 5,000 shares | +4% | |
| 52Moderate | Fortress Biotech, Inc. | Lindsay A Rosenwald Md President, CEO & Chairman | $37k 5,000 shares | +4% | |
| 47Moderate | Fortress Biotech, Inc. | Lindsay A Rosenwald Md President, CEO & Chairman | $33k 20,000 shares | +1% | |
| 20Weak | FBIOsell Fortress Biotech, Inc. | Dov Klein director | $19k 10,000 shares | -16% | |
| 28Weak | FBIObuy Fortress Biotech, Inc. | Lindsay A Rosenwald Md President, CEO & Chairman | $18k 10,000 shares | +0% | |
| 48Moderate | FBIObuy Fortress Biotech, Inc. | Lindsay A Rosenwald Md President, CEO & Chairman | $119k 50,000 shares | +2% | |
| 57Moderate | Fortress Biotech, Inc. | Michael S Weiss See Remarks | $250k 147,058 shares | +15% | |
| 86Strong | Fortress Biotech, Inc. | Lindsay A Rosenwald Md President, CEO & Chairman | $2.7M 1,567,515 shares | +152% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.